Cargando…

Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity

Glioblastomas (GBMs) are highly aggressive brain tumors that have developed resistance to currently available conventional therapies, including surgery, radiation, and systemic chemotherapy. In this study, we investigated the safety of a live attenuated Japanese encephalitis vaccine strain (JEV-LAV)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Zhongbing, Zhao, Jing, Li, Yuhua, Zhang, Bin, Hu, Shichuan, Chen, Yanwei, Ma, Jinhu, Shu, Yongheng, Wang, Yunmeng, Cheng, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126305/ https://www.ncbi.nlm.nih.gov/pubmed/37114043 http://dx.doi.org/10.3389/fimmu.2023.982180

Ejemplares similares

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity
por: Zhang, Bin, et al.
Publicado: (2022)

Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system
por: Cheng, Liuliu, et al.
Publicado: (2022)

The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines
por: Li, Yuhua, et al.
Publicado: (2017)

The Effect of Residual Triton X-100 on Structural Stability and Infection Activity of Adenovirus Particles
por: Ma, Jinhu, et al.
Publicado: (2020)

Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports
por: Jia, Na, et al.
Publicado: (2011)

Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice
por: Fang, Enyue, et al.
Publicado: (2022)

Japanese Encephalitis Virus Vaccination Elicits Cross-Reactive HLA-Class I-Restricted CD8 T Cell Response Against Zika Virus Infection
por: Tarbe, Marion, et al.
Publicado: (2020)

Inactivated tick-borne encephalitis vaccine elicits several overlapping waves of T cell response
por: Sycheva, Anastasiia L., et al.
Publicado: (2022)

Live Attenuated Salmonella enterica Expressing and Releasing Cell-Permeable Bax BH3 Peptide Through the MisL Autotransporter System Elicits Antitumor Activity in a Murine Xenograft Model of Human B Non-hodgkin's Lymphoma
por: Mateos-Chávez, Armando Alfredo, et al.
Publicado: (2019)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)

Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine
por: Hills, Susan L., et al.
Publicado: (2021)

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India
por: Bonaparte, Matthew, et al.
Publicado: (2014)

A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
por: Ambuel, Yuping, et al.
Publicado: (2014)

Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
por: Guo, Zong Sheng, et al.
Publicado: (2014)

Erratum: A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
Publicado: (2014)

Gut-Homing Conventional Plasmablasts and CD27(−) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans
por: Toapanta, Franklin R., et al.
Publicado: (2014)

Molecular and clinical relationship between live‐attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis
por: He, Dan, et al.
Publicado: (2018)

Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity
por: Davis, Emily H., et al.
Publicado: (2021)

Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
por: Kingstad-Bakke, Brock, et al.
Publicado: (2021)

Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer
por: Niavarani, Seyedeh-Raheleh, et al.
Publicado: (2023)

Inhibiting TrxR suppresses liver cancer by inducing apoptosis and eliciting potent antitumor immunity
por: Lei, Hong, et al.
Publicado: (2018)

Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity
por: Yu, Xiaojie, et al.
Publicado: (2020)

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
por: Xu, Caili, et al.
Publicado: (2023)

Blockage of Galectin-Receptor Interactions Attenuates Mouse Hepatic Pathology Induced by Toxoplasma gondii Infection
por: He, Jian, et al.
Publicado: (2022)

A bacterial outer membrane vesicle-based click vaccine elicits potent immune response against Staphylococcus aureus in mice
por: Sun, Jingjing, et al.
Publicado: (2023)

Corilagin Attenuates the Parkinsonismin Japanese Encephalitis Virus Induced Parkinsonism
por: Yanbing, Ding, et al.
Publicado: (2018)

Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma
por: Wang, Yichen, et al.
Publicado: (2022)

Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy
por: Casadesús, Ana Victoria, et al.
Publicado: (2022)

Peripheral Injection of Tim-3 Antibody Attenuates VSV Encephalitis by Enhancing MHC-I Presentation
por: Li, Ge, et al.
Publicado: (2021)

Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager
por: Xiao, Xinghui, et al.
Publicado: (2023)

Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation
por: Ben Abdallah, Hakim, et al.
Publicado: (2023)

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
por: Liu, Zuqiang, et al.
Publicado: (2015)

Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein
por: Torres, Nicolas, et al.
Publicado: (2020)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
por: Chettab, Kamel, et al.
Publicado: (2023)

SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties
por: Warren, Michael C., et al.
Publicado: (2023)

A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement
por: Chen, Qier, et al.
Publicado: (2023)

IP-10 Promotes Blood–Brain Barrier Damage by Inducing Tumor Necrosis Factor Alpha Production in Japanese Encephalitis
por: Wang, Ke, et al.
Publicado: (2018)

Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine
por: Lima, Noemia S., et al.
Publicado: (2021)

Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model
por: Tran, Thi-Anh-Thuy, et al.
Publicado: (2023)

A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells
por: Liu, Xinlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f2blv8o78l402oiuro5eje3udn